Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

80.98 -0.06 (-0.07%)

Streaming Delayed Price Updated: 10:39 AM EDT, Jul 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022

April 19, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets

April 11, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC) ↗

March 28, 2022

Via Benzinga

ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors

March 22, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals's Return On Capital Employed Insights ↗

March 16, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) brought in sales totaling $60.93 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 442.75%, resulting in...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide ↗

March 15, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday. The Dow traded up 1.07% to 33,297.32 while the NASDAQ rose 1.81% to 12,809....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 15, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 164.2% to $60.5 during Tuesday's regular session. Incannex Healthcare's stock is trading at a volume of 664.5K...

Via Benzinga

Upbeat Inflation Data, Falling Oil Prices Prop Up Dow ↗

March 15, 2022

Wall Street is eyeing an upbeat session, with the Dow Jones Industrial Average up 377 points at midday.

Via Talk Markets

Mid-Day Market Update: Dow Surges Over 300 Points; Crude Oil Tumbles 8% ↗

March 15, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq gaining more than 200 points on Tuesday. The Dow traded up 1.01% to 33,276.46 while the NASDAQ rose 1.92% to 12,...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Producer Prices Increase 0.8% In February ↗

March 15, 2022

U.S. stocks opened higher this morning, with the Dow Jones surging more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.69% to 33,172.42...

Via Benzinga

ANI Pharma Posts Mixed Bag Q4 Earnings, FY22 Sales Outlook Trails Street Consensus ↗

March 15, 2022

ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q4 revenues were $60.9 million, +6.4% Y/Y, beating the consensus of $56.30 million. Net revenues for generic pharmaceutical...

Via Benzinga

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial ↗

March 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

ANI Pharmaceuticals: Q4 Earnings Insights ↗

March 15, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q4 earnings results on Tuesday, March 15, 2022 at 06:50 AM. Here's what investors need to know about the announcement....

Via Benzinga

ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth

March 15, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals's Earnings Outlook ↗

March 14, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Earnings Scheduled For March 15, 2022 ↗

March 15, 2022

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...

Via Benzinga

ANI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team

February 24, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

ANI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders

January 24, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances ↗

January 05, 2022

Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference

January 03, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail ↗

December 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients...

Via Benzinga

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP

December 21, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada ↗

December 20, 2021

Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

7 of the Best Small-Cap Stocks to Buy Before 2022 ↗

December 16, 2021

With 2021 coming to a close and a new year upon us, it's time to get a head start on some of the best small-cap stocks to buy.

Via InvestorPlace

This Biotech Company Specializing in Brain Disorder Treatments Reports a Stronger Cash Position ↗

December 13, 2021

Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses

November 22, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021

November 22, 2021

From ANI Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.